T Rowe PR Health Science-InvPRHSX
13F holders, Q3 2025 (September 30)5holders +2
2new positions
0sold out
$81.37avg. 13F price*
At the end of Q3 2025, 5 institutions reported holding T Rowe PR Health Science-Inv (PRHSX) in their 13F filings, up 2 from Q2 2025. 2 opened new positions and 0 sold out. The largest holders were Blue Edge Capital, LLC ($237K), Ethos Financial Group, LLC ($204K) and Westside Investment Management, Inc. ($121K).
- Company
- T Rowe PR Health Science-Inv
- CUSIP
- 741480107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $441K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 5,435 shares bought, net +5,435 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Blue Edge Capital, LLC | 0.03% | New | 2,918 | $237K |
| Ethos Financial Group, LLC | 0.02% | New | 2,517 | $204K |
| Westside Investment Management, Inc. | 0.02% | No change | 1,467 | $121K |
| Coston, McIsaac & Partners | 0.01% | No change | 706 | $57K |
| Financial Gravity Asset Management, Inc. | 0.00% | — | 109 | $9K |
"% of holder's portfolio" is PRHSX's weight in each manager's 13F, not the share of T Rowe PR Health Science-Inv the manager owns.